Cargando…
The topoisomerase inhibitor CPT-11 prevents the growth and metastasis of lung cancer cells in nude mice by inhibiting EGFR/MAPK signaling pathway
OBJECTIVE: The topoisomerase inhibitor CPT-11 has been applied in treatment of multiple cancer types. Here, we probed into the possible mechanism of CPT-11 in affecting growth and metastasis of lung cancer (LC) cells, with involvement of the EGFR/MAPK pathway. METHODS: The target protein of CPT-11 w...
Autores principales: | Yin, Yingqiu, Xie, Junling, Peng, Feng, Tan, Liming, Xiao, Yun, Zheng, Huiying, Yin, Lingzhi, Situ, Huijing, Zhang, Shanqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208938/ https://www.ncbi.nlm.nih.gov/pubmed/37251857 http://dx.doi.org/10.1016/j.heliyon.2023.e15805 |
Ejemplares similares
-
CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues
por: Guichard, S, et al.
Publicado: (1999) -
No Alteration in DNA Topoisomerase I Gene Related to CPT‐11 Resistance in Human Lung Cancer
por: Ohashi, Nobuyuki, et al.
Publicado: (1996) -
Pharmacological targeting of NF-κB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells
por: Lagadec, P, et al.
Publicado: (2008) -
Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
por: Vassal, G., et al.
Publicado: (1996) -
Exosomal DNAJB11 promotes the development of pancreatic cancer by modulating the EGFR/MAPK pathway
por: Liu, Peng, et al.
Publicado: (2022)